The First Targeted Liquid Biopsy Platform for Infectious Diseases
Clinical plasma-based molecular testing through Zepto’s CLIA reference laboratory.
Integrated sample-to-result molecular platform deployable within hospital laboratories.
Analytical performance testing and gold standard reference testing support for diagnostics to obtain FDA clearance
